ArticleEuropean journal of clinical pharmacology2025

A novel physiologically-based pharmacokinetic model to estimate reduced CYP3A4 activity in cancer patients utilizing the neutrophil-to-lymphocyte ratio as an inflammatory marker.

David E Coutant et al.PubMed ↗Publisher ↗

No numbers read from the abstract.